For pharmaceutical, life sciences, and medical device companies, supply chain breakdowns not only bring immediate damage to the affected company, but also can threaten human health and well-being by causing medical supply shortages. In this point of view piece PwC highlights how a continuous supply chain monitoring process that begins with supplier selection and relies on key risk indicators and early intervention is essential to preventing and mitigating the impact of supply chain breakdowns.